Sentiment-Signal
25,4
Bearisch
Composite Score (0–100)
Insider (25%)
0
Keine Insider-Käufe
Institutionell (22,5%)
44.6
3 neu, 0 erhöht, -264902626K $ netto
Aktivist (12,5%)
0
Kein 13D/13G
Risikofreier Zins (T-Bills): 3,70% (Stand: 31.03.2026)
Score-Verlauf (90 Tage)
Kritische 8-K Meldungen
| Datum | Meldung | Schwere | Filing | Auszug |
|---|---|---|---|---|
| 13.05.2025 | Item 5.02 — Abgang Schlüsselpersonen | HOCH | SEC | Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; |
| 14.02.2025 | Item 5.02 — Abgang Schlüsselpersonen | HOCH | SEC | Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Co |
| 13.12.2024 | Item 5.02 — Abgang Schlüsselpersonen | HOCH | SEC | BV Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; |
| 08.05.2024 | Item 5.02 — Abgang Schlüsselpersonen | HOCH | SEC | Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Co |
| 20.02.2024 | Item 5.02 — Abgang Schlüsselpersonen | HOCH | SEC | BV Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; |
| 12.10.2023 | Item 5.02 — Abgang Schlüsselpersonen | HOCH | SEC | BV Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers |
| 29.06.2023 | Item 5.02 — Abgang Schlüsselpersonen | HOCH | SEC | Item 5.02 Departure of Directors or Certain Officers; Appointment of Certain Officers. Effective June 29, 2023 |
Stammdaten
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheumatoid arthritis in adult patients; IMBRUVICA to treat adult patients with chronic lymphocytic leukemia (CLL), small lymphocytic lymphoma (SLL), and VENCLEXTA, a BCL-2 inhibitor used to treat adults with CLL or SLL; and MAVYRET to treat patients with chronic HCV genotype 1-6 infection. It also provides CREON, a pancreatic enzyme therapy for exocrine pancreatic insufficiency; Synthroid used in the treatment of hypothyroidism; Linzess/Constella to treat irritable bowel syndrome with constipation and chronic idiopathic constipation; Lupron for the palliative treatment of advanced prostate cancer, endometriosis and central precocious puberty, and patients with anemia caused by uterine fibroids; and Botox therapeutic. In addition, the company offers ORILISSA, a nonpeptide small molecule gonadotropin-releasing hormone antagonist for women with moderate to severe endometriosis pain; Duopa and Duodopa, a levodopa-carbidopa intestinal gel to treat Parkinson's disease; Lumigan/Ganfort, a bimatoprost ophthalmic solution for the reduction of elevated intraocular pressure (IOP) in patients with open angle glaucoma (OAG) or ocular hypertension; Ubrelvy to treat migraine with or without aura in adults; Alphagan/ Combigan, an alpha-adrenergic receptor agonist for the reduction of IOP in patients with OAG; and Restasis, a calcineurin inhibitor immunosuppressant to increase tear production, as well as other eye care products. AbbVie Inc. has a research collaboration with Dragonfly Therapeutics, Inc. The company was incorporated in 2012 and is headquartered in North Chicago, Illinois.
Unternehmen & Branche
| Name | AbbVie Inc. |
|---|---|
| Ticker | ABBV |
| CIK | 0001551152 |
| Boerse | US |
| Sektor | Healthcare |
| Industrie | Drug Manufacturers - General |
| SIC | 2834 · Pharmaceutical Preparations |
Wertpapier & Kennzahlen
| CUSIP | 002874109 |
|---|---|
| ISIN | US0028741090 |
| Typ | Common Stock |
| Marktkapitalisierung | 349,88 Mrd. USD |
| Beta | 0,36 |
| Dividendenrendite | 6,74 % |
Externe Quellen: SEC EDGAR » · FMP-Profil » · Yahoo Finance »
Finanzkennzahlen (SEC XBRL)
| Periode | Filing | Umsatz | Nettoergebnis | EPS | Aktiva | Eigenkapital |
|---|---|---|---|---|---|---|
| 2025-12-31 | 10-K | 61,160,000,000 | 4,226,000,000 | 2.36 | 133,960,000,000 | -3,270,000,000 |
| 2025-09-30 | 10-Q | 15,776,000,000 | 186,000,000 | 0.10 | 133,898,000,000 | -2,642,000,000 |
| 2025-06-30 | 10-Q | 15,423,000,000 | 938,000,000 | 0.52 | 137,182,000,000 | -183,000,000 |
| 2025-03-31 | 10-Q | 13,343,000,000 | 1,286,000,000 | 0.72 | 136,165,000,000 | 1,420,000,000 |
| 2024-12-31 | 10-K | 15,102,000,000 | -22,000,000 | -0.02 | 135,161,000,000 | 3,325,000,000 |
| 2024-09-30 | 10-Q | 14,460,000,000 | 1,561,000,000 | 0.88 | 143,422,000,000 | 6,032,000,000 |
| 2024-06-30 | 10-Q | 14,462,000,000 | 1,370,000,000 | 0.77 | 141,937,000,000 | 6,778,000,000 |
| 2024-03-31 | 10-Q | 12,310,000,000 | 1,369,000,000 | 0.77 | 148,874,000,000 | 8,007,000,000 |
| 2023-12-31 | 10-K | 14,301,000,000 | 822,000,000 | 0.46 | 134,711,000,000 | 10,360,000,000 |
| 2023-09-30 | 10-Q | 13,927,000,000 | 1,778,000,000 | 1.00 | 136,221,000,000 | 12,094,000,000 |
| 2023-06-30 | 10-Q | 13,865,000,000 | 2,024,000,000 | 1.14 | 135,367,000,000 | 12,866,000,000 |
| 2023-03-31 | 10-Q | 12,225,000,000 | 239,000,000 | 0.13 | 134,544,000,000 | 13,274,000,000 |
| 2022-12-31 | 10-K | 15,121,000,000 | 2,473,000,000 | 1.38 | 138,805,000,000 | 17,254,000,000 |
| 2022-09-30 | 10-Q | 14,812,000,000 | 3,949,000,000 | 2.21 | 141,325,000,000 | 15,994,000,000 |
| 2022-06-30 | 10-Q | 14,583,000,000 | 924,000,000 | 0.51 | 143,186,000,000 | 14,653,000,000 |
| 2022-03-31 | 10-Q | 13,538,000,000 | 4,490,000,000 | 2.51 | 143,211,000,000 | 16,283,000,000 |
| 2021-12-31 | 10-K | 14,886,000,000 | 4,044,000,000 | 2.26 | 146,529,000,000 | 15,408,000,000 |
| 2021-09-30 | 10-Q | 14,342,000,000 | 3,179,000,000 | 1.78 | 148,858,000,000 | 13,550,000,000 |
| 2021-06-30 | 10-Q | 13,959,000,000 | 766,000,000 | 0.42 | 147,972,000,000 | 12,569,000,000 |
| 2021-03-31 | 10-Q | 13,010,000,000 | 3,553,000,000 | 1.99 | 150,501,000,000 | 13,710,000,000 |
Fondsaktivität (Vorquartalsvergleich)
| Fonds | Aktuell (Stk) | Vorquartal (Stk) | Veränderung (Stk) | Wert (USD) | Status | Δ | Trend |
|---|---|---|---|---|---|---|---|
| VANGUARD GROUP INC | 180,779,699 | 0 | 180,779,699 | 41,306,353,424 | Neu | +100,0% | |
| BlackRock, Inc. | 151,174,543 | 0 | 151,174,543 | 34,541,871,411 | Neu | +100,0% | |
| STATE STREET CORP | 80,940,931 | 0 | 80,940,931 | 18,494,193,324 | Neu | +100,0% | |
| JPMORGAN CHASE & CO | 53,175,823 | 0 | 53,175,823 | 12,150,144,455 | Neu | +100,0% | |
| GEODE CAPITAL MANAGEMENT, LLC | 44,629,980 | 0 | 44,629,980 | 10,179,098,610 | Neu | +100,0% | |
| MORGAN STANLEY | 40,041,940 | 0 | 40,041,940 | 9,149,183,466 | Neu | +100,0% | |
| BANK OF AMERICA CORP /DE/ | 25,824,399 | 0 | 25,824,399 | 5,900,616,785 | Neu | +100,0% | |
| NORGES BANK | 25,668,761 | 0 | 25,668,761 | 5,865,055,201 | Neu | +100,0% | |
| Capital Research Global Investors | 25,408,200 | 0 | 25,408,200 | 5,805,529,521 | Neu | +100,0% | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 25,169,844 | 0 | 25,169,844 | 5,751,060,095 | Neu | +100,0% | |
| FMR LLC | 22,609,389 | 0 | 22,609,389 | 5,166,019,290 | Neu | +100,0% | |
| NORTHERN TRUST CORP | 21,733,923 | 0 | 21,733,923 | 4,965,984,066 | Neu | +100,0% | |
| WELLINGTON MANAGEMENT GROUP LLP | 14,926,683 | 0 | 14,926,683 | 3,410,597,797 | Neu | +100,0% | |
| FRANKLIN RESOURCES INC | 14,881,504 | 0 | 14,881,504 | 3,400,274,102 | Neu | +100,0% | |
| GOLDMAN SACHS GROUP INC | 13,770,925 | 0 | 13,770,925 | 3,146,518,647 | Neu | +100,0% | |
| Capital World Investors | 13,071,444 | 0 | 13,071,444 | 2,986,777,322 | Neu | +100,0% | |
| UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC | 12,924,311 | 0 | 12,924,311 | 2,953,075,820 | Neu | +100,0% | |
| Legal & General Group Plc | 12,133,331 | 0 | 12,133,331 | 2,772,344,798 | Neu | +100,0% | |
| UBS Group AG | 12,068,220 | 0 | 12,068,220 | 2,757,467,587 | Neu | +100,0% | |
| Capital International Investors | 11,692,765 | 0 | 11,692,765 | 2,671,982,867 | Neu | +100,0% | |
| DEUTSCHE BANK AG\ | 10,129,714 | 0 | 10,129,714 | 2,314,538,352 | Neu | +100,0% | |
| AMERIPRISE FINANCIAL INC | 10,060,638 | 0 | 10,060,638 | 2,298,902,337 | Neu | +100,0% | |
| RAYMOND JAMES FINANCIAL INC | 9,397,734 | 0 | 9,397,734 | 2,148,100,176 | Neu | +100,0% | |
| WELLS FARGO & COMPANY/MN | 9,168,166 | 0 | 9,168,166 | 2,094,834,218 | Neu | +100,0% | |
| DIMENSIONAL FUND ADVISORS LP | 8,279,502 | 0 | 8,279,502 | 1,891,837,338 | Neu | +100,0% | |
| ROYAL BANK OF CANADA | 8,191,169 | 0 | 8,191,169 | 1,871,601,000 | Neu | +100,0% | |
| Invesco Ltd. | 8,107,480 | 0 | 8,107,480 | 1,852,478,084 | Neu | +100,0% | |
| ALLIANCEBERNSTEIN L.P. | 6,709,941 | 0 | 6,709,941 | 1,533,154,419 | Neu | +100,0% | |
| MASSACHUSETTS FINANCIAL SERVICES CO /MA/ | 6,564,258 | 0 | 6,564,258 | 1,499,867,312 | Neu | +100,0% | |
| SOUTH PLAINS FINANCIAL, INC. | 6,474 | 0 | 6,474 | 1,479,216,000 | Neu | +100,0% | |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 6,472,431 | 0 | 6,472,431 | 1,478,885,759 | Neu | +100,0% | |
| JANUS HENDERSON GROUP PLC | 6,402,650 | 0 | 6,402,650 | 1,462,863,500 | Neu | +100,0% | |
| STATE FARM MUTUAL AUTOMOBILE INSURANCE CO | 5,892,808 | 0 | 5,892,808 | 1,346,447,700 | Neu | +100,0% | |
| BARCLAYS PLC | 5,216,245 | 0 | 5,216,245 | 1,191,859,821 | Neu | +100,0% | |
| Swiss National Bank | 4,840,810 | 0 | 4,840,810 | 1,106,076,677 | Neu | +100,0% | |
| CITADEL ADVISORS LLC | 4,199,951 | 0 | 4,199,951 | 959,646,804 | Neu | +100,0% | |
| CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM | 4,198,609 | 0 | 4,198,609 | 959,340,170 | Neu | +100,0% | |
| NORDEA INVESTMENT MANAGEMENT AB | 4,149,959 | 0 | 4,149,959 | 950,631,108 | Neu | +100,0% | |
| HSBC HOLDINGS PLC | 4,064,980 | 0 | 4,064,980 | 929,583,357 | Neu | +100,0% | |
| National Pension Service | 3,856,731 | 0 | 3,856,731 | 881,224,466 | Neu | +100,0% | |
| LPL Financial LLC | 3,853,097 | 0 | 3,853,097 | 880,393,997 | Neu | +100,0% | |
| BNP PARIBAS FINANCIAL MARKETS | 3,122,572 | 0 | 3,122,572 | 879,986,050 | Neu | +100,0% | |
| AMERICAN CENTURY COMPANIES INC | 3,495,917 | 0 | 3,495,917 | 798,782,600 | Neu | +100,0% | |
| Boston Partners | 3,400,221 | 0 | 3,400,221 | 775,923,434 | Neu | +100,0% | |
| BANK OF MONTREAL /CAN/ | 3,221,221 | 0 | 3,221,221 | 736,016,726 | Neu | +100,0% | |
| Robeco Institutional Asset Management B.V. | 3,210,141 | 0 | 3,210,141 | 733,485,117 | Neu | +100,0% | |
| CITIGROUP INC | 3,180,557 | 0 | 3,180,557 | 726,725,406 | Neu | +100,0% | |
| MANUFACTURERS LIFE INSURANCE COMPANY, THE | 2,984,900 | 0 | 2,984,900 | 682,421,995 | Neu | +100,0% | |
| RHUMBLINE ADVISERS | 2,963,121 | 0 | 2,963,121 | 677,043,547 | Neu | +100,0% | |
| Assenagon Asset Management S.A. | 2,957,880 | 0 | 2,957,880 | 675,846,001 | Neu | +100,0% |
Insider-Transaktionen (12 Monate)
| Datum | Insider | Rolle | Typ | Stückzahl | Kurs | Wert (USD) | Δ | Trend |
|---|---|---|---|---|---|---|---|---|
| 2026-03-04 | Purdue David Ryan | Officer, SVP, Controller | Open Market Sale | -5,230 | 233.56 | -1,221,518.80 | -44,8% | |
| 2026-03-02 | Siatis Perry C | Officer, EVP, GC AND SECRETARY | Open Market Sale | -2,600 | 235.26 | -611,676.00 | -22,5% | |
| 2026-03-02 | Siatis Perry C | Officer, EVP, GC AND SECRETARY | Open Market Sale | -5,777 | 233.51 | -1,348,987.27 | -49,5% | |
| 2026-03-02 | Siatis Perry C | Officer, EVP, GC AND SECRETARY | Open Market Sale | -10,291 | 234.66 | -2,414,886.06 | -88,7% | |
| 2026-02-25 | Siatis Perry C | Officer, EVP, GC AND SECRETARY | Open Market Sale | -22,381 | 230.00 | -5,147,630.00 | -189,0% | |
| 2025-08-12 | SALEKI-GERHARDT AZITA | Officer, EVP, CHIEF OPERATIONS OFFICER | Open Market Sale | -42,370 | 198.42 | -8,407,055.40 | -308,6% | |
| 2025-08-05 | Donoghoe Nicholas | Officer, EVP, CHIEF BUS/STRAT OFFICER | Open Market Sale | -3,234 | 198.27 | -641,238.89 | -23,5% | |
| 2025-08-05 | Donoghoe Nicholas | Officer, EVP, CHIEF BUS/STRAT OFFICER | Open Market Sale | -10,061 | 198.59 | -1,998,013.99 | -73,4% |
Top-Fondshalter
Stand: 31.03.2026
| Fonds | Anteile | Wert (USD) | Anteil (%) |
|---|---|---|---|
| OPPENHEIMER & CO INC | 156,065 | 33,942,577 | 47.65 |
| ADAMS DIVERSIFIED EQUITY FUND, INC. | 129,400 | 28,143,206 | 39.51 |
| HARTLINE INVESTMENT CORP/ | 12,311 | 2,677,519 | 3.76 |
| Parrish Capital LLC | 7,862 | 1,709,906 | 2.40 |
| ECLECTIC ASSOCIATES INC /ADV | 5,843 | 1,270,893 | 1.78 |
| MANCHESTER FINANCIAL INC | 4,080 | 887,454 | 1.25 |
| PW Nova Financial Services LLC | 3,660 | 796,014 | 1.12 |
| AVITY INVESTMENT MANAGEMENT INC. | 3,336 | 725,547 | 1.02 |
| Capital Investment Management, Inc. | 2,493 | 542,176 | 0.76 |
| BENDER ROBERT & ASSOCIATES | 2,393 | 520,454 | 0.73 |
| Horizons Wealth Management | 52 | 11,309 | 0.02 |